Share
Journal Information
Original Article
Incidence of Cancer in a Cohort of Spanish Patients With Systemic Lupus Erythematosus
Incidencia de cáncer en una cohorte de pacientes con lupus eritematoso sistémico
Ana Hidalgo-Condea,
, Manuel de Haro Ligerb, Manuel Abarca-Costalagob, Martina Álvarez Pérezc, Pedro Valdivielso-Felicesb, Pedro González-Santosb, Antonio Fernández-Nebrod
Corresponding author
a Hospital Universitario “Virgen de la Victoria”, Malaga, Spain
b Department of Medicine, Faculty of Medicine, Hospital “Virgen de la Victoria”, Universidad de Málaga, Spain
c Department of Medicine, Universidad de Málaga, Spain
d Department of Medicine, Faculty of Medicine, Hospital Regional Universitario, Carlos Haya, Universidad de Málaga, Spain
Article
This article is available in English
Incidence of Cancer in a Cohort of Spanish Patients With Systemic Lupus Erythematosus
Ana Hidalgo-Conde, Manuel de Haro Liger, Manuel Abarca-Costalago, Martina Álvarez Pérez, Pedro Valdivielso-Felices, Pedro González-Santos, Antonio Fernández-Nebro
10.1016/j.reumae.2013.10.002Reumatol Clin. 2013;9:359-64
Special content about COVID-19
- Spontaneous pneumomediastinum: An extra muscular manifestation of anti-MDA5 dermatomyositis. Report of 2 cases
- The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam
- Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatment
- The “autoimmune/inflammatory syndrome induced by adjuvants” (ASIA) after COVID-19 infection: A case report
Publish in
Reumatología Clínica